Threshold And Molecular Templates Merge To Test The Power Of Two

 
• By Joseph Haas

Although a vehicle for Molecular Templates to take its Engineered Toxin Bodies oncology platform public, the combined company also will seek a pathway to approval for Threshold's evofosfamide for pancreatic cancer in Japan.

businessman and businesswoman are shaking hands and exchanging folder after agreement was reached

More from Business

More from Scrip